Drug-monoclonal antibody conjugates
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 28, 1990
Grant Date -
N/A
app pub date -
Nov 23, 1987
filing date -
Nov 23, 1987
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
There is disclosed a drug-monoclonal antibody conjugate wherein the antibody is linked to a antitumor drug using disulfide benzyl carbamate or carbonate as the linker. Also disclosed is a method of delivering an active antitumor drug to the site of tumor cells in a mammal by administering the drug-monoclonal antibody conjugate.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully